Emergent BioSolutions Inc. provided earnings guidance for third quarter of 2020 and raised guidance for the Full Year of 2020. For the third quarter, the Company forecast for total revenues is $420 million to $450 million. For the full year, the company raised forecast for total revenue to be in the range of $1,500 million to $1,600 million compared to previous guidance of $1,175 million to $1,275 million.